This regulatory status, combined with your physician's prescription for a documented medical condition, makes the medication a qualified medical expense under federal tax law
Diabetes Obes Metab 27:583594 Leiter LA, Yoon K-H, Arias P et al (2015) Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study
Compounded semaglutide is manufactured by licensed 503A pharmacies under the same FDA quality standards as brand medications, though compounded formulations are not FDA-approved as distinct products
L-CARNITINE from SPONSER: CARNIPURE Food supplement with L-carnitine tartrate as CarniPure quality from LONZA for ambitious ultra-endurance athletes
In 2024 the Food and Drug Administration added cardiovascular risk as a reason to be prescribed the GLP-1 drug Wegovy, grounded in results from a major trial that showed fewer heart attacks, strokes, and cardiovascular deaths in adults with obesity or overweight and established heart disease